PTPRB
Basic information
Region (hg38): 12:70515870-70637440
Previous symbols: [ "PTPB" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 101 | 10 | 111 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 101 | 13 | 3 |
Variants in PTPRB
This is a list of pathogenic ClinVar variants found in the PTPRB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-70524555-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
12-70532073-C-T | not specified | Uncertain significance (Jul 08, 2022) | ||
12-70532078-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
12-70534512-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
12-70534602-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
12-70534621-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
12-70534853-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
12-70534930-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
12-70536039-C-G | not specified | Uncertain significance (Jan 23, 2023) | ||
12-70536057-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
12-70536069-C-T | not specified | Uncertain significance (Dec 14, 2022) | ||
12-70536070-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
12-70536153-T-C | not specified | Uncertain significance (May 23, 2023) | ||
12-70538219-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
12-70538981-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
12-70538995-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
12-70539627-C-G | not specified | Uncertain significance (Oct 17, 2023) | ||
12-70539645-G-T | not specified | Uncertain significance (May 01, 2024) | ||
12-70539973-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
12-70539991-T-A | not specified | Uncertain significance (Dec 05, 2022) | ||
12-70540862-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
12-70540937-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
12-70544603-T-C | Benign/Likely benign (Nov 01, 2022) | |||
12-70552948-A-G | Uncertain significance (Feb 10, 2021) | |||
12-70552949-T-C | not specified | Uncertain significance (May 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPRB | protein_coding | protein_coding | ENST00000334414 | 34 | 120591 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.502 | 0.498 | 124618 | 0 | 39 | 124657 | 0.000156 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.66 | 1022 | 1.18e+3 | 0.864 | 0.0000628 | 14495 |
Missense in Polyphen | 276 | 396.99 | 0.69524 | 4780 | ||
Synonymous | 1.37 | 419 | 456 | 0.919 | 0.0000254 | 4279 |
Loss of Function | 7.46 | 24 | 107 | 0.223 | 0.00000581 | 1221 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000656 | 0.000656 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000167 | 0.000167 |
Finnish | 0.000146 | 0.000139 |
European (Non-Finnish) | 0.000144 | 0.000133 |
Middle Eastern | 0.000167 | 0.000167 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an important role in blood vessel remodeling and angiogenesis. Not necessary for the initial formation of blood vessels, but is essential for their maintenance and remodeling. Can induce dephosphorylation of TEK/TIE2, CDH5/VE-cadherin and KDR/VEGFR-2. Regulates angiopoietin-TIE2 signaling in endothelial cells. Acts as a negative regulator of TIE2, and controls TIE2 driven endothelial cell proliferation, which in turn affects blood vessel remodeling during embryonic development and determines blood vessel size during perinatal growth. Essential for the maintenance of endothelial cell contact integrity and for the adhesive function of VE-cadherin in endothelial cells and this requires the presence of plakoglobin (By similarity). {ECO:0000250, ECO:0000269|PubMed:19116766, ECO:0000269|PubMed:19136612}.;
- Pathway
- Adherens junction - Homo sapiens (human);Ectoderm Differentiation;Neutrophil degranulation;sprouty regulation of tyrosine kinase signals;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.753
- rvis_EVS
- 0.34
- rvis_percentile_EVS
- 73.68
Haploinsufficiency Scores
- pHI
- 0.283
- hipred
- Y
- hipred_score
- 0.708
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.828
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ptprb
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Zebrafish Information Network
- Gene name
- ptprb
- Affected structure
- blood vessel endothelial cell
- Phenotype tag
- abnormal
- Phenotype quality
- has fewer parts of type
Gene ontology
- Biological process
- angiogenesis;protein dephosphorylation;phosphate-containing compound metabolic process;dephosphorylation;peptidyl-tyrosine dephosphorylation;neutrophil degranulation
- Cellular component
- plasma membrane;integral component of plasma membrane;specific granule membrane;receptor complex;tertiary granule membrane
- Molecular function
- transmembrane receptor protein tyrosine phosphatase activity;protein binding